Park; Min Hee

Patent Applications and Registrations

Patent applications and USPTO patent grants for Park; Min Hee.The latest application filed is for "cid filter and secondary battery comprising the same".

Company Profile

4.11.20

Park; Min Hee - Daejeon KR
PARK; Min Hee - Gyeongsan-si KR
Park; Min Hee - Daegu KR
Park; Min Hee - Gyeongsangbuk-do KR
PARK; Min Hee - Cheongju-si
PARK; MIN HEE - Wonju-si KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
CID Filter And Secondary Battery Comprising The Same App 20220190450 - Park; Min Hee	2022-06-16
Method For Treating A Degenerative Neurological Disorders Comprising Administering Asm Inhibitor App 20220135703 - BAE; Jae Sung ; et al.	2022-05-05
Neuropeptide Y fragment capable of releasing hematopoietic stem cells into blood and treating osteoporosis Grant 11,279,744 - Bae , et al. March 22, 2	2022-03-22
Cylindrical Secondary Battery Including Gasket Having Recess Formed Therein App 20220077526 - Park; Min Hee ; et al.	2022-03-10
Method for treating a neurological disorder comprising administering ASM inhibitors Grant 11,242,529 - Bae , et al. February 8, 2	2022-02-08
2-amino-2-(1,2,3-triazole-4-yl)propane-1,3-diol Derivative Of Novel Compound For Directly Inhibiting Asm Activity, And Use Thereof App 20210188784 - BAE; Jae-Sung ; et al.	2021-06-24
Secondary Battery and Battery Pack Including the Same App 20210167460 - Park; Min Hee ; et al.	2021-06-03
Pharmaceutical composition containing stem cell in which vascular endothelial growth factor is overexpressed as effective ingredient for preventing or treating neurodegenerative disease Grant 11,007,228 - Bae , et al. May 18, 2	2021-05-18
Pharmaceutical Composition For Preventing Or Treating Degenerative Brain Disorders Including Hdl-apom-s1p As Active Ingredient App 20210085697 - Bae; Jae Sung ; et al.	2021-03-25
Hexagonal Column-shaped Battery Cell, Manufacturing Method Therefor, And Battery Module Comprising Same App 20200358126 - PARK; Min-Hee ; et al.	2020-11-12
Nanoparticles For Selective Death Of Cancer Cells Through Ferroptosis, Method Of Preparing The Same, And Use Of The Nanoparticle App 20200261498 - LEE; Kang Won ; et al.	2020-08-20
Method for treating a degenerative neurological disorders comprising administering ASM inhibitor Grant 10,682,373 - Bae , et al.	2020-06-16
Novel Peptide Exhibiting Effect Of Releasing Hematopoietic Stem Cells Into Blood And Osteoporosis Therapeutic Effect And Use The App 20200172592 - Bae; Jae Sung ; et al.	2020-06-04
Composition containing neuropeptide Y for inhibiting side effects of anticancer agents Grant 10,543,254 - Bae , et al. Ja	2020-01-28
Peptides for treating bone diseases and use thereof Grant 10,323,064 - Bae , et al.	2019-06-18
Pharmaceutical Composition Containing Stem Cell In Which Vascular Endothelial Growth Factor Is Overexpressed As Effective Ingredient For Preventing Or Treating Neurodegenerative Disease App 20190030082 - Bae; Jae Sung ; et al.	2019-01-31
Method using an Y1 receptor activator for treating an anticancer agent-induced nephrotoxic injury Grant 10,143,727 - Bae , et al. De	2018-12-04
Composition comprising ASM inhibitor as active ingredient for preventing or treating degenerative neurological disorders Grant 10,098,855 - Bae , et al. October 16, 2	2018-10-16
Method For Treating A Degenerative Neurological Disorders Comprising Administering Asm Inhibitor App 20180264027 - Bae; Jae Sung ; et al.	2018-09-20
Cosmetic Composition For Improving Anti-oxidation, Anti-inflammation And Atopic Skin By Using Fermented Black Tea Liquid As Effective Ingredient And Method Of Preparing The Same App 20170312216 - KIM; Duggu ; et al.	2017-11-02
Novel Peptides For Preventing Or Treating Bone Diseases And Use Thereof App 20170267723 - BAE; JAE SUNG ; et al.	2017-09-21
Y1 receptor activator for treating an anticancer agent-induced nephrotoxic injury App 20170224781 - Bae; Jae Sung ; et al.	2017-08-10
Pharmaceutical composition for preventing or treating osteoporosis which comprises neuropeptide Y as active ingredient Grant 9,724,394 - Bae , et al. August 8, 2	2017-08-08
Method for treating a neurodegenerative disease or depression comprising administering derivatives of 2-amino-2-(1-dodecyl-1H-1,2,3-triazol-4-yl)propane-1,3-diol Grant 9,724,334 - Bae , et al. August 8, 2	2017-08-08
Composition Containing Neuropeptide Y For Inhibiting Side Effects Of Anticancer Agents App 20170189491 - Bae; Jae Sung ; et al.	2017-07-06
Novel Peptides For Preventing Or Treating Bone Diseases And Use Thereof App 20170183381 - Bae; Jae Sung ; et al.	2017-06-29
Peptides for preventing or treating bone diseases and use thereof Grant 9,650,420 - Bae , et al. May 16, 2	2017-05-16
Peptides For Preventing Or Treating Bone Diseases And Use Thereof App 20170081367 - Bae; Jae Sung ; et al.	2017-03-23
Novel Peptides for Preventing or Treating Bone Diseases and Use Thereof App 20170081366 - Bae; Jae Sung ; et al.	2017-03-23
Pharmaceutical Composition for Preventing or Treating Osteoporosis Which Comprises Neuropeptide Y as Active Ingredient App 20160243198 - Bae; Jae Sung ; et al.	2016-08-25
Distributed Generation System And Method Using A Rental Article Having A Flexible Thin Film Solar Cell App 20160189290 - Bae; Seok Hyung ; et al.	2016-06-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.